期刊文献+

探究乌司他丁和多西他赛对人乳腺癌细胞MDA-MB-231增殖、侵袭的影响 被引量:1

Effect of ulinastatin and docetaxel on proliferation and invasion of MDA-MB-231 human breast cancer cells
下载PDF
导出
摘要 目的探究分析乌司他丁和多西他赛对体外培养的人乳腺癌细胞MDA-MB-231增殖、侵袭和迁移能力的影响。方法将人乳腺癌细胞MDA-MB-231随机分为乌司他丁组、多西他赛组、乌司他丁联合多西他赛组以及对照组四个组,分别予以800 U/ml乌司他丁、3. 7μg/ml多西他赛、800 U/ml乌司他丁+3. 7μg/ml多西他赛以及等量生理盐水干预。分别在干预后0 h、24 h、48 h、72 h时点采用CCK8法检测MDA-MB-231的增殖能力,在干预后48 h采用Transwell法检测MDA-MB-231的侵袭、迁移能力。结果与对照组相比,乌司他丁组、多西他赛组、乌司他丁联合多西他赛组24 h、48 h、72 h等各时点MDA-MB-231的增殖能力均明显降低(P <0. 05),且多西他赛组的增殖能力较同时点乌司他丁组较低(P <0. 05),乌司他丁联合多西他赛组各时点增殖能力则明显降低(P <0. 05),组间比较差异明显,具有统计学意义。与对照组相比,乌司他丁组、多西他赛组、乌司他丁联合多西他赛组各组MDA-MB-231细胞侵袭、迁移能力明显降低(P <0. 05),且乌司他丁联合多西他赛组细胞侵袭、迁移能力明显低于多西他赛组及乌司他丁组水平(P <0. 05),多西他赛组细胞侵袭、迁移能力明显低于乌司他丁组(P <0. 05),组间差异具有显著统计学意义。结论乌司他丁与多西他赛均可在一定程度上抑制人乳腺癌细胞MDA-MB-231的增殖、侵袭和迁移,且乌司他丁和多西他赛联合应用抑制效果优势明显。 Objective To investigate and analyze the effect of ulinastatin and docetaxel on proliferation,invasion and migration of MDA-MB-231 human breast cancer cells.Methods Human breast cancer cells MDA-MB-231 were randomly divided into four groups:ulinastatin group,docetaxel group,ulinastatin combined with docetaxel group and control group,with intervention of 800 U/ml ulinastatin,3.7μg/ml docetaxel,800 U/ml ulinastatin+3.7μg/ml docetaxel and same amount of normal saline,respectively.Proliferation ability of MDA-MB-231 was detected by CCK8 method at 0 h,24 h,48 h and 72 h after intervention.Invasion and migration ability of MDA-MB-231 was detected by Transwell method 48 h after intervention.Results Compared with control group,the other three groups had lower proliferation at each timepoints(P<0.05);proliferation of docetaxel group was lower at same time points compared with ulinastatin group(P<0.05),and combination group had significantly lower proliferation ability(P<0.05).Compared with control group,the other three groups had significantly lower invasion and migration ability(P<0.05).Combination group had even lower invasion and migration ability(P<0.05),and docetaxel group had lower cell invasion and migration ability than ulinastatin group(P<0.05).Conclusion Both ulinastatin and docetaxel can inhibit proliferation,invasion and migration of MDA-MB-231 human breast cancer cells to some extent.
作者 李玥婷 施鹏旭 英子伟 姜大庆 LI Yue-ting;SHI Peng-xu;YING Zi-wei(Department of Breast Surgery,Liaoning Cancer Hospital,Shenyang Liaoning 110042,China;Department of Orthopaedics,Liaoning Provincial People's Hospital,Shenyang Liaoning 110000,China)
出处 《临床和实验医学杂志》 2019年第8期823-826,共4页 Journal of Clinical and Experimental Medicine
基金 沈阳市科学技术项目计划(编号:F10-149-9-61)
关键词 人乳腺癌细胞 乌司他丁 多西他赛 增殖 侵袭 迁移 Human breast cancer cells Ulinastatin Docetaxel Proliferation Invasion Migration
  • 相关文献

参考文献15

二级参考文献228

  • 1吴振宇.急性肺损伤的治疗进展[J].医学信息(医学与计算机应用),2014,0(10):497-498. 被引量:2
  • 2王育生,张阳,吕申.乳腺癌细胞原代培养方法的研究[J].大连医科大学学报,2001,23(1):19-20. 被引量:3
  • 3赵波涛,罗庆丰,高玟,黄传生,涂侃.新辅助化疗对乳腺癌激素受体ER、PR表达的影响[J].实用癌症杂志,2014,29(1):8-9. 被引量:7
  • 4康颖,刘红光,邹飞燕,高天舒,谷依学.尿胰蛋白酶抑制剂乌司他丁抗肺癌作用研究[J].南华大学学报(医学版),2007,35(2):168-171. 被引量:3
  • 5孙涛,姜大庆,宋志国,李金鸣.多西紫杉醇对MCF-7人乳腺癌细胞延迟外向钾电流的作用[J].中国医科大学学报,2007,36(2):199-200. 被引量:5
  • 6Sun Z J, Yu T, Chen JS, et al. Effects of uhnastatin and cy- clophosphamide on the growth of xenograft breast cancer and ex- pression of CXC chemokine receptor 4 and matrix metallopro- teinase-9 in cancers [J]. J Int Med Res, 2010, 38 (3): 967-976.
  • 7Banerjee S, Hussain M, Wang Z, et al. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer [J]. Cancer Res, 2007, 67 (8): 3818-3826.
  • 8Fite A, Goua M, Wahle KW, et al. Potentiation of the anti-tu- mour effect of docetaxel by conjugated linoleie acids (CLAs) in breast cancer cells in vitro [J]. Prostaglandins Leukot Essent Fatty Acids, 2007, 77(2): 87-96.
  • 9Kobayashi H, Shinohara H, Takeuchi K, et al. Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis [J]. Cancer Res, 1994, 54 (3): 844-849.
  • 10Falandry C, Canney PA, Freyer G, et al. Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer [Jl. Ann Oncol, 2009, 20 (4): 615- 620.

共引文献207

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部